
After a dozen years moving from product marketing to corporate strategy, Matthew Graybill arrived at GE HealthCare with a deceptively difficult brief: make a vast cardiovascular portfolio feel like one connected idea.

After helping build the modern stent business, the Elixir Medical founder chose a harder brief: support the vessel, then give it back its motion. The result took more than 150 bench iterations, a major technical pivot, and nearly two decades of clinical work.